Hepatitis B issues
Hello Dr.
Lin: (1) What is the probability of transmitting Hepatitis B through saliva and semen? (2) If a person has developed antibodies against Hepatitis B, can they be assured that they will not be infected regardless of contact with a Hepatitis B carrier? (3) For individuals without Hepatitis B antibodies, can receiving the vaccine eliminate the risk of contracting Hepatitis B?
Xiao Dou, 20~29 year old female. Ask Date: 2008/04/30
Dr. Lin Minghui reply Gastroenterology and Hepatology
Hello, Xiao Dou:
1.
In patients with hepatitis B, the virus HBV-DNA can be detected in saliva, semen, and vaginal secretions, indicating sexual transmission.
According to foreign literature, the transmission rate among heterosexuals is approximately 39%, particularly among those with multiple partners, highlighting the importance of avoiding risky sexual behaviors.
Among homosexual men in the United States, the transmission rate is about 24%.
Early domestic studies have reported that heterosexual contact is the most significant route of transmission for acute hepatitis B among adults in Taiwan.
In a study of 60 acute hepatitis B patients, 83% reported heterosexual contact as the only identified risk factor.
2.
The detection rate of HBV in the saliva of acute hepatitis B patients is as high as 76%, while the detection rate in asymptomatic carriers is 37%.
Another study found that in eAg-positive patients, the HBV-DNA positivity rate in the blood was 100%, and in saliva, it was 47%.
For eAg-negative hepatitis B patients, the HBV-DNA positivity rate in the blood was 58.5%, and in saliva, it was 17%.
This indicates that hepatitis B patients carry a certain amount of the virus in their saliva, which can facilitate transmission through saliva.
3.
The primary mode of transmission for hepatitis B is through infected bodily fluids and blood entering the bloodstream via broken skin or mucous membranes.
The likelihood of transmission is related to the viral load, the infectivity of eAg, and the immune status of the infected individual.
4.
Generally, individuals with hepatitis B antibodies are not at risk of contracting the virus.
5.
Vaccination theoretically provides immunity, and about 85% of individuals will develop antibodies after completing the three-dose vaccine series.
However, antibody levels may decline to below effective concentrations approximately 10 years post-vaccination, and some individuals may require a booster.
Wishing you good health,
Dr.
Lin Ming-Hui, Taoyuan Hospital, Department of Health
Reply Date: 2008/04/30
More Info
Hepatitis B is a viral infection that affects the liver and can lead to serious health issues, including chronic liver disease and liver cancer. Understanding its transmission, vaccination, and the body's immune response is crucial for prevention and management. Let's address your questions one by one.
1. Transmission through Saliva and Semen: The risk of transmitting Hepatitis B through saliva is considered to be low. While the virus can be present in saliva, it is not typically transmitted through casual contact or sharing utensils. In contrast, the risk of transmission through semen is significantly higher. Hepatitis B is primarily transmitted through blood, sexual contact, and from mother to child during childbirth. Therefore, while saliva may contain the virus, the likelihood of transmission through this medium is minimal compared to blood and sexual fluids.
2. Immunity from Natural Antibody Production: If a person has developed antibodies against Hepatitis B (anti-HBs), it indicates that they have either cleared a past infection or have been vaccinated. In either case, they are considered immune to the virus. This means that they are unlikely to contract Hepatitis B from exposure to an infected individual, including contact with bodily fluids. However, it is important to note that immunity can wane over time, and regular monitoring of antibody levels may be advisable, especially for those at higher risk.
3. Vaccination and Protection Against Hepatitis B: For individuals who do not have antibodies against Hepatitis B, vaccination is the most effective way to prevent infection. The Hepatitis B vaccine is highly effective, and after completing the vaccination series, most individuals will develop protective antibodies. This means that vaccinated individuals can significantly reduce their risk of contracting Hepatitis B, even if they come into contact with the virus. However, it is essential to complete the full vaccination series and have follow-up blood tests to confirm that adequate immunity has been achieved.
In summary, while the risk of transmission through saliva is low, the risk through semen is significant. Individuals with natural immunity (anti-HBs positive) are generally protected from infection, while those without immunity should receive the vaccine to prevent Hepatitis B. Regular monitoring and follow-up with healthcare providers are crucial for managing health and ensuring adequate protection against this virus.
Additionally, it is important to practice safe behaviors, such as using protection during sexual activity and avoiding sharing personal items that may come into contact with blood, to further reduce the risk of transmission. If you have concerns about potential exposure or vaccination status, consulting with a healthcare provider for personalized advice and testing is recommended.
Similar Q&A
Understanding Hepatitis B: Vaccine Efficacy and Transmission Risks
I apologize, but I would like to ask: I received the hepatitis B vaccine two years ago, and at that time, I had no hepatitis B antigens or antibodies. I donated blood two months ago, and the blood donation center did not find any abnormalities. Two weeks ago, I underwent a health...
Dr. Zeng Guosen reply Internal Medicine
Individuals who have been vaccinated and have sufficient antibody levels are unlikely to become infected and will not transmit the virus to others. Thank you for your question.[Read More] Understanding Hepatitis B: Vaccine Efficacy and Transmission Risks
Understanding Hepatitis B Vaccination and Blood Transfusion Risks
Having received the hepatitis B vaccine and confirmed the presence of antibodies indicates a strong level of protection against hepatitis B virus (HBV) infection. However, while vaccination significantly reduces the risk of contracting hepatitis B, it does not guarantee absolute ...
Dr. Xiao Yongxun reply Internal Medicine
1. In our country, if the hepatitis B vaccine is administered according to the schedule, it will produce antibodies against the hepatitis B surface antigen, thus providing protection; you are currently in this situation. 2. On the other hand, blood donation centers conduct screen...[Read More] Understanding Hepatitis B Vaccination and Blood Transfusion Risks
Assessing Hepatitis B Transmission Risk from Blood Splash to Eyes
If a patient is a carrier of hepatitis B but has low infectivity, and there was a splash of blood during a blood glucose measurement that got into the eyes, but the individual has been vaccinated against hepatitis B and has antibodies, is the risk of transmission still high?
Dr. Xiao Yongxun reply Family Medicine
Dear Miss Hsiao-Hsuan: 1. Since 1985, almost all newborns in our country have received complete vaccinations against hepatitis B. Therefore, since your test still shows the presence of hepatitis B antibodies, the chance of contracting hepatitis B is nearly nonexistent. 2. The...[Read More] Assessing Hepatitis B Transmission Risk from Blood Splash to Eyes
Understanding Hepatitis B: Infection, Epidemiology, and Public Health Interventions
Public health perspectives on hepatitis B include various aspects such as transmission, epidemiology, prevalence, treatment and prognosis, morbidity and mechanisms, as well as public health interventions. Hepatitis B is primarily transmitted through contact with infectious body...
Dr. Hong Shouhong reply Family Medicine
Chronic hepatitis is most commonly caused by chronic viral hepatitis, which can be divided into two types: hepatitis B and hepatitis C. Once infected, if the body is unable to produce antibodies to eliminate the virus, the virus may persist in the liver, potentially leading to a ...[Read More] Understanding Hepatitis B: Infection, Epidemiology, and Public Health Interventions
Related FAQ
(Gastroenterology and Hepatology)
Hepatitis B Vaccine(Gastroenterology and Hepatology)
Hepatitis B Infection Risk(Gastroenterology and Hepatology)
Hepatitis B Antibodies(Gastroenterology and Hepatology)
Hepatitis B Screening(Gastroenterology and Hepatology)
Hepatitis B Medication(Gastroenterology and Hepatology)
Viral Infection(Gastroenterology and Hepatology)
Helicobacter Pylori(Gastroenterology and Hepatology)
Hepatitis B(Obstetrics and Gynecology)
Hepatitis B Vaccine(Family Medicine)